Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human allogeneic bone marrow derived osteoblastic-like cells

EU orphan designation number: EU/3/13/1176   
Active ingredient: Human allogeneic bone marrow derived osteoblastic-like cells
Indication: Treatment of non-traumatic osteonecrosis
Sponsor: Bone Therapeutics SA
8 rue Adrienne Bolland, B-6041 Gosselies, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan Designation EMA/OD/070/13 (2013)5275 of 05/08/2013